Arsenal Biosciences cuts ‘majority’ of staff in move to in vivo CAR-T
Roughly a year after shedding half of its workforce, Arsenal Biosciences is trimming its headcount again by letting go of “the majority” of its staffers as a result of a pivot into in vivo CAR-T ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.